Article

Choroidal thickening plays a role in emmetropization

Increases in choroidal thickening are integral to ocular growth andvision, as demonstrated in bird models, and are not merely afocusing mechanism, according to one physician.

Increases in choroidal thickening are integral to ocular growth and vision, as demonstrated in bird models, and are not merely a focusing mechanism, according to one physician.

The choroid was found to be important in regulating the refractive state of the eye about 10 years ago when it was discovered in chicks that changes in the thickness of the choroid were a compensatory response that moved the retina toward the image plane. This occurs before the scleral changes that result in variations in the size of the eye, according to Debora Nickla, PhD, from the New England College of Optometry, Boston. She spoke at the annual meeting of the Association for Research in Vision and Ophthalmology.

Dr. Nickla hypothesized that transient daily increases in choroid thickness are part of the pathway mediating axial growth inhibition. Nitric oxide may be the underlying mechanism based on experiments using nitric oxide inhibitors. A series of experiments in birds supported her hypothesis.

"Preventing the development of myopia is associated with choroidal thickening linking the choroidal response to growth inhibition," Dr. Nickla said.

Apomorphine, which inhibits growth, resulted in increases in choroidal thickness and in choroidal nitric oxide.

"All evidence to date supports the hypothesis that the choroidal response plays a causal role in ocular growth regulation," she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.